Use of an In Vitro Pharmacodynamic Model To Derive a Moxifloxacin Regimen That Optimizes Kill of Yersinia pestis and Prevents Emergence of Resistance
Louie, A., Heine, H. S., VanScoy, B., Eichas, A., Files, K., Fikes, S., Brown, D. L., Liu, W., Kinzig-Schippers, M., Sorgel, F., Drusano, G. L.Volume:
55
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.00818-10
Date:
February, 2011
File:
PDF, 937 KB
english, 2011